Geneos Wealth Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.5K Hold
7,100
– – ﹤0.01% 1536
2026
Q1
$27.5K Hold
7,100
– – ﹤0.01% 1655
2025
Q4
$29.7K Hold
7,100
– – ﹤0.01% 1589
2025
Q3
$23.4K Buy
7,100
+900
+15% +$2.54K ﹤0.01% 1670
2025
Q2
$8.8K Buy
6,200
+4,550
+276% +$6.47K ﹤0.01% 2371
2025
Q1
$2.46K Buy
1,650
+400
+32% +$630 ﹤0.01% 2709
2024
Q4
$1.4K Buy
1,250
+250
+25% +$213 ﹤0.01% 2690
2024
Q3
$950 Hold
1,000
– – ﹤0.01% 2459
2024
Q2
$1.58K Sell
1,000
-44
-4% -$64 ﹤0.01% 1922
2024
Q1
$1.51K Buy
1,044
+44
+4% +$63 ﹤0.01% 1945
2023
Q4
$1.34K Hold
1,000
– – ﹤0.01% 1979
2023
Q3
$1.42K Buy
1,000
+199
+25% +$282 ﹤0.01% 1984
2023
Q2
$921 Hold
801
– – ﹤0.01% 2028
2023
Q1
$849 Hold
801
– – ﹤0.01% 2008
2022
Q4
$1.22K Buy
801
+300
+60% +$516 ﹤0.01% 1940
2022
Q3
$1K Sell
501
-7,677
-94% -$16.2K ﹤0.01% 1957
2022
Q2
$11K Sell
8,178
-500
-6% -$742 ﹤0.01% 1912
2022
Q1
$18K Hold
8,678
– – ﹤0.01% 1863
2021
Q4
$32K Sell
8,678
-100
-1% -$430 ﹤0.01% 1673
2021
Q3
$44K Buy
8,778
+1
+0% +$6 ﹤0.01% 1551
2021
Q2
$56K Hold
8,777
– – ﹤0.01% 1420
2021
Q1
$67K Hold
8,777
– – ﹤0.01% 1477
2020
Q4
$65K Sell
8,777
-900
-9% -$5.83K ﹤0.01% 1327
2020
Q3
$34K Hold
9,677
– – ﹤0.01% 1413
2020
Q2
$47K Sell
9,677
-95
-1% -$323 ﹤0.01% 1243
2020
Q1
$30K Buy
+9,772
New +$42.2K ﹤0.01% 1346

Other funds holding PGEN

Geneos Wealth Management's PGEN Position: Q2 2026 in Review

Geneos Wealth Management held its Precigen (PGEN) position steady in Q2 2026 at 7,100 shares worth $40.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1536.

Geneos Wealth Management first reported a position in PGEN in Q1 2020 and has held it in 26 quarters since. The position peaked at $67K in Q1 2021. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Geneos Wealth Management held 7,100 shares of Precigen worth $40.5K as of Q2 2026.
  • Geneos Wealth Management left its Precigen share count unchanged in Q2 2026.
  • Precigen made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1536 holding.
  • Geneos Wealth Management first reported a position in Precigen in Q1 2020 and has held it in 26 quarters since.
  • Geneos Wealth Management's Precigen position peaked at $67K in Q1 2021.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.